Thyrocare Technologies Statistics
Total Valuation
NSE:THYROCARE has a market cap or net worth of INR 66.54 billion. The enterprise value is 64.86 billion.
| Market Cap | 66.54B |
| Enterprise Value | 64.86B |
Important Dates
The next estimated earnings date is Monday, May 11, 2026.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | Oct 24, 2025 |
Share Statistics
| Current Share Class | 159.16M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.87% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 62.01M |
Valuation Ratios
The trailing PE ratio is 48.40 and the forward PE ratio is 36.38.
| PE Ratio | 48.40 |
| Forward PE | 36.38 |
| PS Ratio | 8.40 |
| PB Ratio | 12.46 |
| P/TBV Ratio | 15.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 47.18 |
| EV / Sales | 8.19 |
| EV / EBITDA | 26.23 |
| EV / EBIT | 34.76 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | n/a |
| Interest Coverage | 93.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 35.28% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.49% |
| Revenue Per Employee | 4.35M |
| Profits Per Employee | 754,555 |
| Employee Count | 1,822 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:THYROCARE has paid 599.20 million in taxes.
| Income Tax | 599.20M |
| Effective Tax Rate | 30.65% |
Stock Price Statistics
The stock price has increased by +74.06% in the last 52 weeks. The beta is 0.23, so NSE:THYROCARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +74.06% |
| 50-Day Moving Average | 437.45 |
| 200-Day Moving Average | 410.81 |
| Relative Strength Index (RSI) | 47.37 |
| Average Volume (20 Days) | 390,119 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:THYROCARE had revenue of INR 7.92 billion and earned 1.37 billion in profits. Earnings per share was 8.75.
| Revenue | 7.92B |
| Gross Profit | 4.20B |
| Operating Income | 1.86B |
| Pretax Income | 1.95B |
| Net Income | 1.37B |
| EBITDA | 2.39B |
| EBIT | 1.86B |
| Earnings Per Share (EPS) | 8.75 |
Balance Sheet
The company has 1.92 billion in cash and 246.80 million in debt, with a net cash position of 1.68 billion.
| Cash & Cash Equivalents | 1.92B |
| Total Debt | 246.80M |
| Net Cash | 1.68B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.34B |
| Book Value Per Share | 33.60 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.06%, with operating and profit margins of 23.53% and 17.35%.
| Gross Margin | 53.06% |
| Operating Margin | 23.53% |
| Pretax Margin | 24.68% |
| Profit Margin | 17.35% |
| EBITDA Margin | 30.12% |
| EBIT Margin | 23.53% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 9.33, which amounts to a dividend yield of 2.22%.
| Dividend Per Share | 9.33 |
| Dividend Yield | 2.22% |
| Dividend Growth (YoY) | 55.56% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 1.87% |
| Shareholder Yield | 4.09% |
| Earnings Yield | 2.07% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 28, 2025. It was a forward split with a ratio of 3.
| Last Split Date | Nov 28, 2025 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |